关于完善我国糖尿病患者肺结核筛查政策的思考

doi:10.19982/j.issn.1000-6621.20230436

摘要/Abstract

摘要：

糖尿病不仅增加结核病的发病风险,还会增加结核病患者治疗的失败、复发和死亡风险。基于现有的研究发现,在我国糖尿病患者中大规模开展结核病筛查总体收益不高,在高负担地区或存在高危因素的糖尿病患者中开展结核病筛查或许是一个更佳的选择,具有较高的成本-效益。本文中,笔者指出了目前我国糖尿病患者结核病筛查存在的问题,并介绍了相应的对策与建议。

关键词: 结核, 肺, 糖尿病, 筛查, 政策制订

Abstract:

Diabetes not only increases the risk of tuberculosis, but also increases treatment failure, recurrence and death in tuberculosis patients. Based on the existing studies, the large-scale tuberculosis screening among diabetes patients in China had low yields. It may be more cost-effective to carry out tuberculosis screening in high-burden areas or diabetes patients with high-risk factors. In this paper, the author pointed out the existing problems of tuberculosis screening in diabetes patients in China, and pointed out the corresponding plans and suggestions.

Key words: Tuberculosis, pulmonary, Diabetes mellitus, Screening, Policy making

中图分类号:

R521
R587.1

竺丽梅. 关于完善我国糖尿病患者肺结核筛查政策的思考[J]. 中国防痨杂志, 2024, 46(3): 267-271. doi: 10.19982/j.issn.1000-6621.20230436

Zhu Limei. Thoughts on improving the tuberculosis screening policy in diabetes patients in China[J]. Chinese Journal of Antituberculosis, 2024, 46(3): 267-271. doi: 10.19982/j.issn.1000-6621.20230436

参考文献 31

[1]	Nagendra L, Boro H, Mannar V. Bacterial infections in diabetes. South Dartmouth (MA): MDText.com, Inc, 2000.
[2]	Knapp S. Diabetes and infection: is there a link? A mini-review. Gerontology, 2013, 59(2): 99-104. doi:10.1159/000345107.
[3]	杨旭堃, 刘权贤, 张娟, 等. 2型糖尿病合并肺结核感染患者初诊临床特征分析. 临床军医杂志, 2023, 51(8): 776-780, 785. doi:10.16680/j.1671-3826.2023.08.02.
[4]	董航, 杜映荣. 糖尿病与肺结核共病的临床研究进展. 结核与肺部疾病杂志, 2022, 3(1):65-69. doi:10.19983/j.issn.2096-8493.20210121.
[5]	Stevenson CR, Critchley JA, Forouhi NG, et al. Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn, 2007, 3(3):228-245. doi:10.1177/1742395307081502.
[6]	Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med, 2008, 5(7): e152. doi:10.1371/journal.pmed.0050152.
[7]	World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020.
[8]	Martinez L, Zhu L, Castellanos ME, et al. Glycemic Control and the Prevalence of Tuberculosis Infection: A Population-based Observational Study. Clin Infect Dis, 2017, 65(12): 2060-2068. doi:10.1093/cid/cix632. pmid: 29059298
[9]	Yoo JE, Kim D, Han K, et al. Diabetes Status and Association With Risk of Tuberculosis Among Korean Adults. JAMA Netw Open, 2021, 4(9): e2126099. doi:10.1001/jamanetworkopen.2021.26099.
[10]	Baker MA, Harries AD, Jeon CY, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med, 2011, 9: 81. doi:10.1186/1741-7015-9-81. pmid: 21722362
[11]	World Health Organization. Systematic screening for active tuberculosis: an operational guide. Geneva: World Health Organization, 2015.
[12]	田瑶, 刘辉敏, 傅满姣, 等. 结核病与糖尿病共病诊疗现状. 结核与肺部疾病杂志, 2022, 3(2): 91-95. doi:10.19983/j.issn.2096-8493.20210111.
[13]	World Health Organization. Global tuberculosis report 2022. Geneva: World Health Organization, 2022.
[14]	徐静, 罗萍, 贺晓新. 肺结核合并糖尿病与单纯肺结核患者流行特征对比分析. 中国防痨杂志, 2022, 44 (5): 494-499. doi:10.19982/j.issn.1000-6621.20220047.
[15]	张国钦, 陈盛玉, 张玉华, 等. 天津市城区肺结核合并糖尿病的流行病学特征分析. 中国慢性病预防与控制, 2016, 24(1): 14-18. doi:10.16386/j.cjpccd.issn.1004-6194.2016.01.005.
[16]	Zheng C, Hu M, Gao F. Diabetes and pulmonary tuberculosis: a global overview with special focus on the situation in Asian countries with high TB-DM burden. Glob Health Action, 2017, 10(1): 1-11. doi:10.1080/16549716.2016.1264702.
[17]	Lin Y, Li L, Mi F, et al. Screening patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health, 2012, 17(10): 1302-1308. doi:10.1111/j.1365-3156.2012.03069.x. pmid: 22830951
[18]	Lin Y, Innes A, Xu L, et al. Screening of patients with diabetes mellitus for tuberculosis in community health settings in China. Trop Med Int Health, 2015, 20(8): 1073-1080. doi:10.1111/tmi.12519. pmid: 25877338
[19]	Zhao W, Shi L, Fonseca VA, et al. Screening patients with type 2 diabetes for active tuberculosis in communities of China. Diabetes Care, 2013, 36(9): e159-160. doi:10.2337/dc13-1007.
[20]	汪娟, 许缃, 蔡晓峰, 等. 对糖尿病患者进行肺结核筛查的效果与成本效益分析. 中国防痨杂志, 2019, 41(9): 968-973. doi:10.3969/j.issn.1000-6621.2019.09.011.
[21]	张慧, 成君, 于艳玲, 等. 基于社区的重点人群肺结核主动发现干预效果评价:多中心前瞻性队列研究. 中国防痨杂志, 2021, 43(12): 1248-1259. doi:10.3969/j.issn.1000-6621.2021.12.005.
[22]	国家感染性疾病临床医学研究中心, 深圳市第三人民医院, 国家代谢性疾病临床医学研究中心, 等. 结核病与糖尿病共病的治疗管理专家共识. 中国防痨杂志, 2021, 43(1):12-22. doi:10.3969/j.issn.1000-6621.2021.01.004.
[23]	中国疾病预防控制中心结核病预防控制中心. 中国结核病防治工作技术指南. 北京: 人民卫生出版社, 2021.
[24]	Liu Q, You N, Wen J, et al. Yield and Efficiency of a Population-Based Mass Tuberculosis Screening Intervention Among Persons With Diabetes in Jiangsu Province, China. Clin Infect Dis, 2023, 77(1):103-111. doi:10.1093/cid/ciad118. pmid: 36869807
[25]	Ji Y, Cao H, Liu Q, et al. Screening for pulmonary tuberculosis in high-risk groups of diabetic patients. Int J Infect Dis, 2020, 93:84-89. doi:10.1016/j.ijid.2020.01.019. pmid: 31978585
[26]	杨敏, 付亮, 邓国防. 结核病并发糖尿病治疗管理相关进展. 中国防痨杂志, 2021, 43(1):87-90. doi:10.3969/j.issn.1000-6621.2021.01.016.
[27]	邓国防, 成诗明. 浅谈我国结核病与糖尿病共病治疗管理现状. 中国防痨杂志, 2021, 43(1):23-25. doi:10.3969/j.issn.1000-6621.2021.01.005.
[28]	The Union, the World Diabetes Foundation. Management of diabetes mellitus-tuberculosis. a guide to the essential practice. Paris: The Union, 2019.
[29]	中国防痨协会. T/CHATA 014—2021 糖尿病患者肺结核筛查规范. 2021-07-09.
[30]	林岩, 邓国防. 糖尿病并发结核病治疗中多学科合作应注意的问题. 中国防痨杂志, 2021, 43(7): 649-652. doi:10.3969/j.issn.1000-6621.2021.07.002.
[31]	毛毅, 范琳, 刘勇. 肺结核并发糖尿病的诊治研究进展. 中国防痨杂志, 2019, 41(12):1325-1329. doi:10.3969/j.issn.1000-6621.2019.12.015.